| 1 |
Diekema DJ, Hsueh PR, Mendes RE, et al. The microbiology of bloodstream infection: 20-year trends from the sentry antimicrobial surveillance program[J]. Antimicrob Agents Chemother, 2019, 63(7): e00355-19.
|
| 2 |
Tabah A, Buetti N, Staiquly Q, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study[J]. Intensive Care Med, 2023, 49(2): 178-190.
|
| 3 |
Deresinski S. Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data[J]. Clin Infect Dis, 2007, 45(Suppl 3): S177-183.
|
| 4 |
Adrie C, Garrouste-Orgeas M, Ibn Essaied W, et al; OUTCOMEREA Study Group. Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile and antimicrobial therapy[J]. J Infect, 2017, 74(2): 131-141.
|
| 5 |
中国医疗保健国际交流促进会临床微生物与感染分会, 中华医学会检验医学分会临床微生物学组, 中华医学会微生物学和免疫学分会临床微生物学组. 血液培养技术用于血流感染诊断临床实践专家共识[J]. 中华检验医学杂志, 2022, 45(2): 105-121.
|
| 6 |
上海市微生物学会临床微生物学专业委员会, 上海市医学会检验医学专科分会, 上海市医学会危重病专科分会. 血流感染临床检验路径专家共识[J]. 中华传染病杂志, 2022, 40(8): 457.
|
| 7 |
赵志强. 血培养三级报告在临床应用中的评价[J]. 国际检验医学杂志, 2013, 34(14): 1904-1905.
|
| 8 |
冯雪, 周永列. 血培养三级报告临床应用结果分析[J]. 中国微生态学杂志, 2016, 28(12): 1450-1452.
|
| 9 |
陆文香, 吴培南, 徐卫东. 血培养三级报告临床应用结果分析[J]. 临床检验杂志, 2012, 30(5): 380-381.
|
| 10 |
Klevens RM, Edwards JR, Andrus ML, et al. Dialysis surveillance report: National Healthcare Safety Network (NHSN)-data summary for 2006[J]. Semin Dial, 2008, 21(1): 24-28.
|
| 11 |
中国初级卫生保健基金会检验医学研究与转化专业委员会, 中国医院协会临床微生物实验室专业委员会. 侵袭性霉菌感染实验室诊断临床应用专家共识[J]. 中华检验医学杂志, 2024, 47(6): 597-609.
|
| 12 |
陈云波, 嵇金如, 刘志盈, 等. 全国血流感染细菌耐药监测 (BRICS) 2021年度报告[J]. 中华临床感染病杂志, 2023, 16(1): 33-47.
|
| 13 |
Lodise TP, McKinnon PS, Swiderski L, et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia[J]. Clin Infect Dis, 2003, 36(11): 1418-1423.
|
| 14 |
De Bus L, Arvaniti K, Sjövall F. Empirical antimicrobials in the intensive care unit[J]. Intensive Care Med, 2024, 50(8): 1338-1341.
|
| 15 |
Bonomo RA, Chow AW, Edwards MS, et al. 2024 clinical practice guideline update by the Infectious Diseases Society of America on complicated intra-abdominal infections: risk assessment, diagnostic imaging, and microbiological evaluation in adults, children, and pregnant people[J]. Clin Infect Dis, 2024, 79(Suppl 3): S81-S87.
|
| 16 |
胡付品, 郭燕, 朱德妹, 等. 2021年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2022, 22(5): 521.
|
| 17 |
Gilbert DN, Chambers HF, Saag MS, et al. The Sanford guide to antimicrobial therapy [M]. 50th. 钟南山,等, 译. 中国医药科技出版社, 2008.
|
| 18 |
Stevens DL, Bisno AL, Chambers HF, et al; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2014, 59(2): 147-159.
|
| 19 |
Paul M, Kariv G, Goldberg E, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia[J]. J Antimicrob Chemother, 2010, 65(12): 2658-2665.
|
| 20 |
Lodise TP Jr, McKinnon PS, Levine DP, et al. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2007, 51(10): 3731-3733.
|
| 21 |
Delgado V, Ajmone Marsan N, de Waha S, et al; ESC Scientific Document Group. 2023 ESC Guidelines for the management of endocarditis[J]. Eur Heart J, 2023, 44(39): 3948-4042.
|
| 22 |
娄荣玲. 形态学检查法在临床细菌鉴定中的作用[J]. 检验医学与临床, 2009, 6(5): 381-382.
|
| 23 |
张卓然, 倪语星. 临床微生物学和微生物检验学 [M]. 北京: 人民卫生出版社, 2003: 233.
|
| 24 |
产超广谱β内酰胺酶细菌感染防治专家委员会. 产超广谱β内酰胺酶细菌感染防治专家共识[J/OL]. 中华实验和临床感染病杂志(电子版), 2010, 4(2): 207-214.
|
| 25 |
Tamma PD, Aitken SL, Bonomo RA, et al. Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant Gram-negative infections[J]. Clin Infect Dis, 2023, 18: ciad 428.
|
| 26 |
中华医学会呼吸病学分会感染学组. 中国铜绿假单胞菌下呼吸道感染诊治专家共识(2022版)[J]. 中华结核和呼吸杂志, 2022, 45(8): 739.
|
| 27 |
Tschudin-Sutter S, Fosse N, Frei R, et al. Combination therapy for treatment of Pseudomonas aeruginosa bloodstream infections[J]. PLoS One, 2018, 13(9): e0203295.
|
| 28 |
Micek ST, Lloyd AE, Ritchie DJ, et al. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment[J]. Antimicrob Agents Chemother, 2005, 49(4): 1306-1311.
|
| 29 |
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(4): 253-279.
|
| 30 |
Silva-Santana G, Silva CMF, Olivella JGB, et al. Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976-2020[J]. Arch Microbiol, 2021, 203(5): 1863-1880.
|
| 31 |
Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2009, 49(1): 1-45.
|